Search Results 141-150 of 19690 for Portal hypertension
Douglas (Doug) A. Simonetto, M.D., studies complications of cirrhosis and noncirrhotic portal hypertension, with a focus on ascites and hepatorenal syndrome, ...
Lu C, Yoo M, De Luigi AJ. Chronic exertional compartment syndrome in a patient with restrictive cardiomyopathy and portal hypertension. J Osteopath Med 2022 ...
They've been involved with clinical studies for pulmonary hypertension for many years. You may have the opportunity to participate in clinical trials for ...
Von Willebrand factor antigen, a correlate of portal hypertension. To support broader clinical adoption of this model, the research team developed a ...
Participation eligibility · Chronic portal hypertension from intrinsic liver disease or portal vein disease, documented by clinical history or liver biopsy.
... pulmonary medicine. Focus areas. Portal hypertension. Dr. Vargas researches the management and treatment of hepatorenal syndrome, conducts vasoactive therapy ...
The purpose of this study is to assess the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary arterial hypertension.
Pulmonary arterial hypertension; Advanced left heart disease; Mechanical circulatory support recipients. Dr. Frantz is Director of the Pulmonary Hypertension ...
... hypertension, Interstitial lung disease, Pulmonary fibrosis, Hepatopulmonary syndrome, Pulmonary valve disease. Show more areas of focus for Kelly M ...
The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension. Participation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.